Denna sida har översatts automatiskt och översättningens korrekthet kan inte garanteras. Vänligen se engelsk version för en källtext.

The Study of Perioperative Intravenous Infusion of Lidocaine on Postoperative Analgesia in Patients Undergoing Single-port Thoracoscopic

The purpose of this study is to evaluate the effect of intravenous lidocaine infusion on pain and opioid dosage in patients undergoing single-port thoracoscopic surgery,and to evaluate the effects of perioperative catecholamine levels, extubation time, incidence of nausea and vomiting, patient satisfaction and hospital stay.

Studieöversikt

Status

Okänd

Betingelser

Detaljerad beskrivning

The World Congress on Pain identified pain as the "fifth leading indicator of human life" after breathing, pulse, body temperature and blood pressure. Postoperative pain is an acute nociceptive pain caused by surgical trauma and is a complex stress response in the body, especially in 72 hours after surgery. Pain after thoracic surgery is a more severe type of surgery in various types of surgery.

Acute pain at the early stage of operation is not only an external signal of body injury, but also an independent factor inducing stress response and systemic inflammatory response syndrome (SIRS). Pain stimulus can also cause excessive release of catecholamine, damage of vascular endothelial cells and neutrophil aggregation, which can induce cytokine "waterfall" secretion. Stress, pain and inflammation induce and interact with each other, which seriously affects the early recovery of patients after operation. Timely and effective post-operative analgesia can not only alleviate patients'pain, but also avoid a series of stress reactions. It provides favorable conditions for the stability of patients' physiological function and recovery of their body after operation.

Although multimodal analgesia has largely replaced monotherapy with opioids, they are still the most commonly used drugs for postoperative pain. Lidocaine is an amide local anesthetic which when used intravenously demonstrates significant analgesic, anti-hyperalgesic and anti-inflammatory properties .

Intravenous infusion of lidocaine has a good effect on fibromyalgia, chronic neuropathic pain, opioid tolerance and other chronic pain, and can reduce postoperative acute pain. In the 1960s, Barlett et al. first published a study on the use of lidocaine intravenous infusion for postoperative analgesia.Since then, more and more researchers have begun to explore the use of lidocaine in the treatment of postoperative acute pain.In 2007, Kaba et al. selected patients who underwent colectomy as an experimental subject, and intravenously injected lidocaine during the perioperative period. The results showed that the pain of the experimental group was effectively relieved and the use of opioids was reduced. In 2008, Lauwick et al. used laparoscopic cholecystectomy as the experimental subject. The results showed that the dose of opioid analgesia in the lidocaine group was significantly lower than that in the control group, and the postoperative pain was effectively improved. In 2009, Yardeni et al. selected patients undergoing total hysterectomy as experimental subjects and intravenously injected lidocaine during the perioperative period. The results confirmed that the hemodynamics of the experimental group was more stable, the average dosage of anesthetics was reduced, and the pain was significantly improved.However, to date, there is no strong evidence for the effect of perioperative intravenous infusion of lidocaine in single-port thoracoscopic surgery, so we designed this study.

Studietyp

Interventionell

Inskrivning (Förväntat)

80

Fas

  • Fas 4

Kontakter och platser

Det här avsnittet innehåller kontaktuppgifter för dem som genomför studien och information om var denna studie genomförs.

Studieorter

    • Zhejiang
      • Hangzhou, Zhejiang, Kina, 310009
        • Rekrytering
        • The Second Affiliated Hospital Zhejiang University School of Medicine
        • Kontakt:

Deltagandekriterier

Forskare letar efter personer som passar en viss beskrivning, så kallade behörighetskriterier. Några exempel på dessa kriterier är en persons allmänna hälsotillstånd eller tidigare behandlingar.

Urvalskriterier

Åldrar som är berättigade till studier

18 år till 70 år (Vuxen, Äldre vuxen)

Tar emot friska volontärer

Nej

Kön som är behöriga för studier

Allt

Beskrivning

Inclusion Criteria:

  • Patients undergoing single-port thoracoscopic with a left double lumen bronchial catheter
  • Age ≧ 18 years old, ≦70 years old
  • Temperature, white blood cells, and hemoglobin were normal before surgery
  • Patient informed consent

Exclusion Criteria:

  • Patients with a history of surgery within six months
  • Patients with dysfunction of heart, liver, kidney, lung, pancreas or other important organs
  • American Society of Anesthesiologists (ASA) physical Status classes ≧ Ⅲ
  • Allergic to lidocaine
  • Bradycardia (heart rate < 60 beats/min) or atrioventricular block
  • Mental disorder
  • Patients requiring a right double lumen bronchial catheter

Studieplan

Det här avsnittet ger detaljer om studieplanen, inklusive hur studien är utformad och vad studien mäter.

Hur är studien utformad?

Designdetaljer

  • Primärt syfte: Behandling
  • Tilldelning: Randomiserad
  • Interventionsmodell: Parallellt uppdrag
  • Maskning: Dubbel

Vapen och interventioner

Deltagargrupp / Arm
Intervention / Behandling
Experimentell: Lidocaine group
First group (lidocaine group) will include those who receive a intraoperative lidocaine infusion.Induction bolus dose of 1.5 mg/kg body weight ( 30 minutes before incision)followed by a continous lidocaine infusion of 2mg/kg/h,until 1 hours after skin closure.
regimen of lidocaine administration of 1.5 mg/kg, IV bolus, followed by continuous infusion at 2 mg/kg/h
Placebo-jämförare: Saline group
The second group(saline group) will include those who receive a intraoperative placebo.The same dosage of saline was given according to the same method of administration in the lidocaine group.
IV bolus of saline, followed by continuous infusion of saline

Vad mäter studien?

Primära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
Postoperative pain score
Tidsram: Immediately postoperation
Using Visual Analogue Scales
Immediately postoperation
Postoperative pain score
Tidsram: 1 hour postoperation
Using Visual Analogue Scales
1 hour postoperation
Postoperative pain score
Tidsram: 4 hours postoperation
Using Visual Analogue Scales
4 hours postoperation
Postoperative pain score
Tidsram: 8 hours postoperation
Using Visual Analogue Scales
8 hours postoperation
Postoperative pain score
Tidsram: 24 hours postoperation
Using Visual Analogue Scales
24 hours postoperation
Postoperative pain score
Tidsram: 48 hours postoperation
Using Visual Analogue Scales
48 hours postoperation

Sekundära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
Opioid requirement
Tidsram: Immediately postoperation
The dosage of opioids was recorded
Immediately postoperation
Opioid requirement
Tidsram: 1 hour postoperation
The dosage of opioids was recorded
1 hour postoperation
Opioid requirement
Tidsram: 4 hours postoperation
The dosage of opioids was recorded
4 hours postoperation
Opioid requirement
Tidsram: 8 hours postoperation
The dosage of opioids was recorded
8 hours postoperation
Opioid requirement
Tidsram: 24 hours postoperation
The dosage of opioids was recorded
24 hours postoperation
Opioid requirement
Tidsram: 48 hours postoperation
The dosage of opioids was recorded
48 hours postoperation
Pressing times of PCIA postoperation
Tidsram: 48 hours postoperation
The pressing times of PCIA within 48 hours postoperation was recorded
48 hours postoperation
Occurrence of nausea and/or vomiting
Tidsram: 48 hours postoperation
The occurrence of nausea and vomiting within 48 hours postoperation was recorded
48 hours postoperation
Blood level of adrenaline
Tidsram: before induction
Perioperative blood level of adrenaline was recorded
before induction
Blood level of adrenaline
Tidsram: after incision
Perioperative blood level of adrenaline was recorded
after incision
Blood level of adrenaline
Tidsram: immediately after extubation
Perioperative blood level of adrenaline was recorded
immediately after extubation
Blood level of norepinephrine
Tidsram: before induction
Perioperative blood level of norepinephrine was recorded
before induction
Blood level of norepinephrine
Tidsram: after incision
Perioperative blood level of norepinephrine was recorded
after incision
Blood level of norepinephrine
Tidsram: immediately after extubation
Perioperative blood level of norepinephrine was recorded
immediately after extubation
Blood level of adrenocortical
Tidsram: before induction
Perioperative blood level of adrenocortical was recorded
before induction
Blood level of adrenocortical
Tidsram: after incision
Perioperative blood level of adrenocortical was recorded
after incision
Blood level of adrenocortical
Tidsram: immediately after extubation
Perioperative blood level of adrenocortical was recorded
immediately after extubation
Blood level of TNF-alpha
Tidsram: before induction
Perioperative blood level of TNF-alpha was recorded
before induction
Blood level of TNF-alpha
Tidsram: after incision
Perioperative blood level of TNF-alpha was recorded
after incision
Blood level of TNF-alpha
Tidsram: immediately after extubation
Perioperative blood level of TNF-alpha was recorded
immediately after extubation
Blood level of IL-6
Tidsram: before induction
Perioperative blood level of IL-6 was recorded
before induction
Blood level of IL-6
Tidsram: after incision
Perioperative blood level of IL-6 was recorded
after incision
Blood level of IL-6
Tidsram: immediately after extubation
Perioperative blood level of IL-6 was recorded
immediately after extubation
Blood level of IL-10
Tidsram: before induction
Perioperative blood level of IL-10 was recorded
before induction
Blood level of IL-10
Tidsram: after incision
Perioperative blood level of IL-10 was recorded
after incision
Blood level of IL-10
Tidsram: immediately after extubation
Perioperative blood level of IL-10 was recorded
immediately after extubation
Duration of hospital stay
Tidsram: from day of surgery until day of discharge from hospital
length of hospital stay (in days)
from day of surgery until day of discharge from hospital

Samarbetspartners och utredare

Det är här du hittar personer och organisationer som är involverade i denna studie.

Utredare

  • Studiestol: Congcong Chen, Second Affiliated Hospital, School of Medicine, Zhejiang University

Publikationer och användbara länkar

Den som ansvarar för att lägga in information om studien tillhandahåller frivilligt dessa publikationer. Dessa kan handla om allt som har med studien att göra.

Allmänna publikationer

Studieavstämningsdatum

Dessa datum spårar framstegen för inlämningar av studieposter och sammanfattande resultat till ClinicalTrials.gov. Studieposter och rapporterade resultat granskas av National Library of Medicine (NLM) för att säkerställa att de uppfyller specifika kvalitetskontrollstandarder innan de publiceras på den offentliga webbplatsen.

Studera stora datum

Studiestart (Förväntat)

1 augusti 2019

Primärt slutförande (Förväntat)

31 december 2019

Avslutad studie (Förväntat)

31 december 2020

Studieregistreringsdatum

Först inskickad

19 juli 2019

Först inskickad som uppfyllde QC-kriterierna

31 juli 2019

Första postat (Faktisk)

2 augusti 2019

Uppdateringar av studier

Senaste uppdatering publicerad (Faktisk)

2 augusti 2019

Senaste inskickade uppdateringen som uppfyllde QC-kriterierna

31 juli 2019

Senast verifierad

1 juli 2019

Mer information

Termer relaterade till denna studie

Läkemedels- och apparatinformation, studiedokument

Studerar en amerikansk FDA-reglerad läkemedelsprodukt

Nej

Studerar en amerikansk FDA-reglerad produktprodukt

Nej

Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .

Prenumerera